Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oxycodone vs tramadol for moderate cancer pain in multi-ethnic patients
ChiCTR2500107474Phase 4Not yet recruiting
- Sponsor
- Sichuan Cancer Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cancer pain comparing Oxycodone sustained-release with Tramadol sustained-release (2 arms). Primary endpoint: Numeric Rating Scale pain score (NRS) at day 28. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
oxycodonetramadol
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2500107474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107474.